Bristol-Myers Squibb Company (BMY)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	48,300,000	47,435,000	46,509,000	45,534,000	45,006,000	44,935,000	45,187,000	45,848,000	46,159,000	46,738,000	47,144,000	46,960,000	46,385,000	45,468,000	44,384,000	42,810,000	42,518,000	39,395,000	34,862,000	31,006,000
Total assets	US$ in thousands	92,603,000	93,670,000	94,646,000	99,031,000	95,159,000	91,263,000	93,489,000	94,281,000	96,820,000	98,196,000	100,357,000	103,034,000	109,314,000	110,893,000	110,797,000	112,435,000	118,481,000	125,536,000	128,076,000	129,285,000
Total asset turnover		0.52	0.51	0.49	0.46	0.47	0.49	0.48	0.49	0.48	0.48	0.47	0.46	0.42	0.41	0.40	0.38	0.36	0.31	0.27	0.24

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $48,300,000K ÷ $92,603,000K
= 0.52

Total asset turnover for Bristol-Myers Squibb Company has been on an upward trend over the past few years, indicating an improvement in the company's efficiency in generating sales from its total assets. The ratio increased from 0.24 in March 2020 to 0.52 in December 2024. This suggests that the company is utilizing its assets more effectively to generate revenue. It peaked at 0.52 in December 2024, indicating that for every dollar of assets the company had, it generated $0.52 in sales. Overall, the increasing trend in total asset turnover reflects positively on Bristol-Myers Squibb Company's operational efficiency and performance.